brinzolamide 1%/brimonidine 0.2% fixed combination
CQVJ499A2404
Approved small_molecule completed
Quick answer
brinzolamide 1%/brimonidine 0.2% fixed combination for Glaucoma is a Approved program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Glaucoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed